trilaciclib: Clinical Trials

2 trials of trilaciclib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Active not recruiting 1, Completed 1

Follow trilaciclib: new trials by email Literature Review of trilaciclib trials Research Report on trilaciclib

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan
Trilaciclib, Placebo, Topotecan - Extensive-stage Small-cell Lung Cancer
Phase 4Active not recruitingPharmacosmos A/S3022023-10-132026-10-05
Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study
Trilaciclib - Extensive-stage Small-cell Lung Cancer
Phase 4CompletedJiangsu Simcere Pharmaceutical Co., Ltd.302021-08-112023-10-06

Conditions studied

Small Cell Lung Carcinoma (2)

Sponsors

Jiangsu Simcere Pharmaceutical Co., Ltd. (1)  ·  Pharmacosmos A/S (1)

Countries

China (1)  ·  Spain (1)

Top investigators

Yongxing Chen (1)